Sökning: onr:"swepub:oai:DiVA.org:uu-520215" >
Were cancer patient...
-
Johansson, Anna L., VKarolinska Institutet,Canc Registry Norway, POB 5313 Majorstuen, N-0304 Oslo, Norway.;Karolinska Inst, Dept Med Epidemiol & Biostat, POB 281, SE-17177 Stockholm, Sweden.
(författare)
Were cancer patients worse off than the general population during the COVID-19 pandemic? : A population-based study from Norway, Denmark and Iceland during the pre-vaccination era
- Artikel/kapitelEngelska2023
Förlag, utgivningsår, omfång ...
-
Elsevier,2023
-
electronicrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:uu-520215
-
https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-520215URI
-
https://doi.org/10.1016/j.lanepe.2023.100680DOI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:154350797URI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Background In a population-based setting, we investigated the risks of testing positive for SARS-CoV-2 and developing severe COVID-19 outcomes among cancer patients compared with the general population.Methods In nationwide cohorts, we identified all individuals in Norway, Denmark and Iceland who tested positive for SARS-CoV-2 or had a severe COVID-19 outcome (hospitalisation, intensive care, and death) from March until December 2020, using data from national health registries. We estimated standardised incidence ratios (SIRs) with 95% confidence intervals (CIs) comparing cancer patients with the general population.Findings During the first wave of the pandemic, cancer patients in Norway and Denmark had higher risks of testing SARS-CoV-2 positive compared to the general population. Throughout 2020, recently treated cancer patients were more likely to test SARS-CoV-2 positive. In Iceland, cancer patients experienced no increased risk of testing positive. The risk of COVID-19-related hospitalisation was higher among cancer patients diagnosed within one year of hospitalisation (Norway: SIR = 2.43, 95% CI 1.89-3.09; Denmark: 2.23, 1.96-2.54) and within five years (Norway: 1.58, 1.35-1.83; Denmark: 1.54, 1.42-1.66). Risks were higher in recently treated cancer patients and in those diagnosed with haematologic malignancies, colorectal or lung cancer. Risks of COVID-19-related intensive care and death were higher among cancer patients. Interpretation Cancer patients were at increased risk of testing positive for SARS-CoV-2 during the first pandemic wave when testing availability was limited, while relative risks of severe COVID-19 outcomes remained increased in cancer patients throughout 2020. Recent cancer treatment and haematologic malignancy were the strongest risk factors.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Skog, AnnaCanc Registry Norway, POB 5313 Majorstuen, N-0304 Oslo, Norway.
(författare)
-
Johannesen, Tom BorgeCanc Registry Norway, POB 5313 Majorstuen, N-0304 Oslo, Norway.
(författare)
-
Myklebust, Tor ageCanc Registry Norway, POB 5313 Majorstuen, N-0304 Oslo, Norway.;More & Romsdal Hosp Trust, Dept Res & Innovat, Alesund, Norway.
(författare)
-
Skovlund, Charlotte WesselDanish Canc Soc Res Ctr, Danish Canc Soc, Canc Surveillance & Pharmacoepidemiol, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.
(författare)
-
Morch, Lina SteinrudDanish Canc Soc Res Ctr, Danish Canc Soc, Canc Surveillance & Pharmacoepidemiol, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.
(författare)
-
Friis, SorenDanish Canc Soc Res Ctr, Danish Canc Soc, Canc Surveillance & Pharmacoepidemiol, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.
(författare)
-
Gamborg, MadsDanish Canc Soc Res Ctr, Danish Canc Soc, Canc Surveillance & Pharmacoepidemiol, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.
(författare)
-
Kristiansen, Marnar FrioheimFac Hlth Sci, Ctr Hlth Sci, Torshavn, Faroe Islands.;Natl Hosp Faroe Isl, Torshavn, Faroe Islands.
(författare)
-
Pettersson, DavidNatl Board Hlth & Welf, SE-10630 Stockholm, Sweden.
(författare)
-
Olafsdottir, Elinborg J.Iceland Canc Soc, ICS Res & Registrat Ctr, POB 5420, IS-105 Reykjavik, Iceland.
(författare)
-
Birgisson, HelgiIceland Canc Soc, ICS Res & Registrat Ctr, POB 5420, IS-105 Reykjavik, Iceland.
(författare)
-
Palsson, RunolfurLandspitali The Natl Univ Hosp Iceland, Saemundargata 2, IS-102 Reykjavik, Iceland.;Univ Iceland, Reykjavik, Iceland.
(författare)
-
Eythorsson, EliasLandspitali The Natl Univ Hosp Iceland, Saemundargata 2, IS-102 Reykjavik, Iceland.
(författare)
-
Irenaeus, SandraUppsala universitet,Cancerimmunterapi,Akadem Sjukhuset, Reg Canc Ctr Cent Sweden, SE-75185 Uppsala, Sweden.(Swepub:uu)sanir765
(författare)
-
Lambe, MatsKarolinska Institutet,Karolinska Inst, Dept Med Epidemiol & Biostat, POB 281, SE-17177 Stockholm, Sweden.;Akadem Sjukhuset, Reg Canc Ctr Cent Sweden, SE-75185 Uppsala, Sweden.
(författare)
-
Ursin, GiskeCanc Registry Norway, POB 5313 Majorstuen, N-0304 Oslo, Norway.;Univ Oslo, Inst Basic Med Sci, Oslo, Norway.;Univ Southern Calif, Dept Prevent Med, Los Angeles, CA USA.
(författare)
-
Karolinska InstitutetCanc Registry Norway, POB 5313 Majorstuen, N-0304 Oslo, Norway.;Karolinska Inst, Dept Med Epidemiol & Biostat, POB 281, SE-17177 Stockholm, Sweden.
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:The Lancet Regional Health: Elsevier312666-7762
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Johansson, Anna ...
-
Skog, Anna
-
Johannesen, Tom ...
-
Myklebust, Tor a ...
-
Skovlund, Charlo ...
-
Morch, Lina Stei ...
-
visa fler...
-
Friis, Soren
-
Gamborg, Mads
-
Kristiansen, Mar ...
-
Pettersson, Davi ...
-
Olafsdottir, Eli ...
-
Birgisson, Helgi
-
Palsson, Runolfu ...
-
Eythorsson, Elia ...
-
Irenaeus, Sandra
-
Lambe, Mats
-
Ursin, Giske
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Infektionsmedici ...
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Hälsovetenskap
-
och Folkhälsovetensk ...
- Artiklar i publikationen
-
The Lancet Regio ...
- Av lärosätet
-
Uppsala universitet
-
Karolinska Institutet